MeyerLab
Okarmus J., Havelund J.F., Ryding M., Schmidt S.I., Bogetofte H., Heon-Roberts R., Ryan B.J., Cowley, S.A., Wade-Martins R., Færgeman N.J., Hyttel P., Meyer M. (2021). Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: altered mitochondrial and energy metabolism (Stem Cell Reports, DOI.org/: 10.1016/j.stemcr.2021.04.022)
Jensen B.R., Malling A.S.B., Schmidt S.I., Meyer M., Morberg B.M., Wermuth L. (2021). Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson’s disease (PLoS ONE, doi.org/10.1371 /journal.pone.0248800)
Ferreira N., Gram H., Sorrentino Z.A., Gregersen E., Schmidt S.I., Betzer C., Perez-Gozalbo C., Beltoja M., Nagaraj M., Wang J., Nowak J.S., Dong M., Bjerregaard-Andersen K., Otzen D., Akbey Ü., Meyer M., Giasson B., Romero-Ramos M., Jensen P.H. (2021). Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurotoxicity (Acta Neuropathologica, doi: 10.1007/s00401-021-02316-0)
Madsen D.A., Schmidt S.I., Jensen P.H., Meyer M. (2021). Interaction between parkin and -synuclein in PARK2-mediated Parkinson’s disease (Cells, 10, 283, doi.org/10.3390/ cells10020283)
Schmidt S.I., Bogetofte H., Ritter L., Agergaard J.B., Hammerich D., Kabiljagic A.A., Wlodarczyk A., Lopez S.G., Sørensen M.D., Jørgensen M.L., Okarmus J., Serrano A.M., Kristensen B.W., Freude K., Owens T., Meyer M. (2021) Microglia-secreted factors enhance dopaminergic differentiation of tissue- and iPSC-derived human neural stem cells (Stem Cell Reports, DOI.org/10.1016/j.stemcr.2020.12.011).
Okarmus J., Bogetofte H., Schmidt S.I., Ryding M., Lopez S.G., Ryan B.J., Martinez-Serrano A., Hyttel P., Meyer M. (2020) Lysosomal perturbations in dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation (Scientific Reports, doi.org/10.1038/s41598-020-67091-6).
Bogetofte H., Jensen P., Okarmus J., Schmidt S.I., Agger M., Ryding M., Nørregaard P., Fenger C., Zeng X., Graakjær J., Ryan B., Wade-Martins R., Larsen M.R., and Meyer M. (2019). Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation (Neurobiology of Disease, DOI.org/10.1016/j.nbd.2019.104581).
Bogetofte H., Jensen P., Ryding M., Schmidt S.I., Okarmus J., Ritter L., Worm C.S., Hohnholt M.C., Azevedo C., Roybon L., Bak L.K., Waagepetersen H., Ryan B.J., Wade-Martins R., Larsen M.R., Meyer M. (2019). PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons (Frontiers in Cellular Neuroscience, DOI.org/10.3389/fncel.2019.00297).
Okarmus J., Bogetofte H., Schmidt S.I., Ryding M., Lopez S.G., Martínez-Serrano A., Hyttel P., Meyer M. (2019) Lysosomal perturbations in dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation (bioRxiv/2019/DOI.org/10.734244).
Hey S.M., Jensen P., Ryding M., Martines-Serrano A., Kristensen B.W., Meyer M. (2019). Non-hypoxic pharmacological stabilisation of Hypoxia Inducible Factor 1α: effects on dopaminergic differentiation of human neural stem cells (Eur. J. Neurosci.; DOI: 10.1111/ejn.14284).
Dreyer-Andersen N., Almeida A.S., Jensen P., Kamand M., Okarmus J., Rosenberg T., Friis S.D., Martínez Serrano A., Blaabjerg M., Kristensen B.W., Skrydstrup T., Gramsbergen J.B., Vieira H.L.A., Meyer M. (2018). Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells (PLoS ONE, 13, 1, s. e0191207).
Dindler A, Blaabjerg M, Kamand M, Bogetofte H, Meyer M. (2017). Activation of Group II metabotropic glutamate receptors increases proliferation but does not influence neuronal differentiation of a human neural stem cell line (Basic & Clin. Pharm. & Tox., DOI: 10.1111/bcpt.12920).
Johansen T, Krabbe C, Schmidt SI, Serrano AM, Meyer M. (2017). Comparative analysis of spontaneous and stimulus-evoked calcium transients in proliferating and differentiating human midbrain-derived stem cells (Stem Cells International, DOI: 10.1155/2017/9605432).